300 related articles for article (PubMed ID: 29682242)
1. Eradication of
Fakheri H; Saberi Firoozi M; Bari Z
Middle East J Dig Dis; 2018 Jan; 10(1):5-17. PubMed ID: 29682242
[No Abstract] [Full Text] [Related]
2. Helicobacter pylori eradication in West Asia: a review.
Fakheri H; Bari Z; Aarabi M; Malekzadeh R
World J Gastroenterol; 2014 Aug; 20(30):10355-67. PubMed ID: 25132752
[TBL] [Abstract][Full Text] [Related]
3. Optimum duration of regimens for Helicobacter pylori eradication.
Yuan Y; Ford AC; Khan KJ; Gisbert JP; Forman D; Leontiadis GI; Tse F; Calvet X; Fallone C; Fischbach L; Oderda G; Bazzoli F; Moayyedi P
Cochrane Database Syst Rev; 2013 Dec; (12):CD008337. PubMed ID: 24338763
[TBL] [Abstract][Full Text] [Related]
4. High Efficacy of Levofloxacin-Dexlansoprazole-Based Quadruple Therapy as a First Line Treatment for Helicobacter pylori Eradication in Thailand.
Prapitpaiboon H; Mahachai V; Vilaichone RK
Asian Pac J Cancer Prev; 2015; 16(10):4353-6. PubMed ID: 26028098
[TBL] [Abstract][Full Text] [Related]
5. Toward population specific and personalized treatment of Helicobacter pylori infection.
Liou JM; Chen PY; Kuo YT; Wu MS;
J Biomed Sci; 2018 Oct; 25(1):70. PubMed ID: 30285834
[TBL] [Abstract][Full Text] [Related]
6. Novel and Effective Therapeutic Regimens for
Hu Y; Zhu Y; Lu NH
Front Cell Infect Microbiol; 2017; 7():168. PubMed ID: 28529929
[No Abstract] [Full Text] [Related]
7. 'Rescue' therapies for the management of Helicobacter pylori infection.
Di Mario F; Cavallaro LG; Scarpignato C
Dig Dis; 2006; 24(1-2):113-30. PubMed ID: 16699270
[TBL] [Abstract][Full Text] [Related]
8. Second-line rescue treatment of
Lin TF; Hsu PI
World J Gastroenterol; 2018 Oct; 24(40):4548-4553. PubMed ID: 30386104
[TBL] [Abstract][Full Text] [Related]
9. Update on the first-line treatment of
Shih CA; Shie CB; Hsu PI
Therap Adv Gastroenterol; 2022; 15():17562848221138168. PubMed ID: 36458050
[TBL] [Abstract][Full Text] [Related]
10. Comparison of quadruple and triple Furazolidone containing regimens on eradication of helicobacter pylori.
Mokhtare M; Hosseini V; Tirgar Fakheri H; Maleki I; Taghvaei T; Valizadeh SM; Sardarian H; Agah S; Khalilian A
Med J Islam Repub Iran; 2015; 29():195. PubMed ID: 26157713
[TBL] [Abstract][Full Text] [Related]
11. A comparison between sequential therapy and a modified bismuth-based quadruple therapy for Helicobacter pylori eradication in Iran: a randomized clinical trial.
Fakheri H; Taghvaei T; Hosseini V; Bari Z
Helicobacter; 2012 Feb; 17(1):43-8. PubMed ID: 22221615
[TBL] [Abstract][Full Text] [Related]
12. Eradication of Helicobacter pylori infection.
Wu TS; Hu HM; Kuo FC; Kuo CH
Kaohsiung J Med Sci; 2014 Apr; 30(4):167-72. PubMed ID: 24656156
[TBL] [Abstract][Full Text] [Related]
13. [Helicobacter pylori - 2012].
Buzás GM
Orv Hetil; 2012 Sep; 153(36):1407-18. PubMed ID: 22951408
[TBL] [Abstract][Full Text] [Related]
14. Helicobacter pylori-related diseases.
Gisbert JP
Gastroenterol Hepatol; 2016 Sep; 39 Suppl 1():36-46. PubMed ID: 27888863
[TBL] [Abstract][Full Text] [Related]
15. Second-line rescue triple therapy with levofloxacin after failure of non-bismuth quadruple "sequential" or "concomitant" treatment to eradicate H. pylori infection.
Gisbert JP; Molina-Infante J; Marin AC; Vinagre G; Barrio J; McNicholl AG
Scand J Gastroenterol; 2013 Jun; 48(6):652-6. PubMed ID: 23556551
[TBL] [Abstract][Full Text] [Related]
16. Reevaluation of the Efficacy of First Line Regimen for
Tariq H; Patel H; Kamal MU; Abbas N; Ameen M; Azam S; Kumar K; Ravi M; Vootla V; Shaikh D; Amanchi V; Hussain AN; Makker J
Clin Exp Gastroenterol; 2020; 13():25-33. PubMed ID: 32158248
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of Clarithromycin Containing Bismuth-Based Regimen as a Second-Line Therapy in Helicobacter Pylori Eradication.
Mokhtare M; Agah S; Fakheri H; Hosseini V; Rezaei Hemami M; Ghafoori SM
Middle East J Dig Dis; 2015 Apr; 7(2):75-81. PubMed ID: 26106466
[TBL] [Abstract][Full Text] [Related]
18. Bismuth supplements as the first-line regimen for Helicobacter pylori eradication therapy: Systemic review and meta-analysis.
Ko SW; Kim YJ; Chung WC; Lee SJ
Helicobacter; 2019 Apr; 24(2):e12565. PubMed ID: 30698318
[TBL] [Abstract][Full Text] [Related]
19. Helicobacter pylori.
Malfertheiner P; Selgrad M
Curr Opin Gastroenterol; 2014 Nov; 30(6):589-95. PubMed ID: 25268839
[TBL] [Abstract][Full Text] [Related]
20. Reconciliation of Recent Helicobacter pylori Treatment Guidelines in a Time of Increasing Resistance to Antibiotics.
Fallone CA; Moss SF; Malfertheiner P
Gastroenterology; 2019 Jul; 157(1):44-53. PubMed ID: 30998990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
